NASDAQ: VSEEVsee Health Inc Stock
$1.61+0.01 (+0.63%)
Updated Dec 9, 2024
VSEE Price
$1.61
Fair Value Price
-$0.29
Market Cap
$25.22M
52 Week Low
$1.12
52 Week High
$33.08
P/E
-0.38x
P/B
5.3x
P/S
3.42x
PEG
N/A
Dividend Yield
N/A
Revenue
$6.56M
Earnings
-$54.95M
Gross Margin
72.4%
Operating Margin
-845.01%
Profit Margin
-837.3%
Debt to Equity
4.26
Operating Cash Flow
-$3M
Beta
0.14
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
VSEE Overview
Digital Health Acquisition Corp. is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations. It targets technology and healthcare-focused businesses. Digital Health Acquisition was incorporated in 2021 and is based in Boca Raton, FL.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine VSEE's potential to beat the market
FStrong Sell
- Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More
Zen Rating Component Grades
F
Value
D
Growth
D
Momentum
C
Sentiment
F
Safety
D
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
C
VSEE
Ranked#52 of 52
Ranked#52 of 52
Be the first to know about important VSEE news, forecast changes, insider trades & much more!
VSEE News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how VSEE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
VSEE ($1.61) is overvalued by 664.74% relative to our estimate of its Fair Value price of -$0.29 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
VSEE ($1.61) is not significantly undervalued (664.74%) relative to our estimate of its Fair Value price of -$0.29 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
VSEE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more VSEE due diligence checks available for Premium users.
Valuation
VSEE fair value
Fair Value of VSEE stock based on Discounted Cash Flow (DCF)
Price
$1.61
Fair Value
-$0.29
Undervalued by
664.74%
VSEE ($1.61) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
VSEE ($1.61) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
VSEE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
VSEE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.38x
Industry
24.56x
Market
29.44x
VSEE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.3x
Industry
3.86x
VSEE is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
VSEE's financial health
Profit margin
Revenue
$3.4M
Net Income
-$51.8M
Profit Margin
-1,542.8%
VSEE's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
VSEE's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$25.0M
Liabilities
$20.3M
Debt to equity
4.26
VSEE's short-term liabilities ($19.21M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VSEE's short-term assets ($7.11M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VSEE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$221.0k
Investing
-$5.0k
Financing
$1.4M
VSEE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
VSEE vs Health Information Service Stocks
Vsee Health Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.